Market updates: Immunovant, Infleqtion, and International Flavors & Fragrances

Various companies and investment firms have seen notable activity in recent market reports. Two Seas Capital LP acquired a significant new position in Immunovant, Inc., purchasing 3,148,505 shares valued at approximately $121,312,000 during the second quarter. This acquisition represents about 1.52% of Immunovant.

In the quantum technology sector, Infleqtion received an upgrade from Wall Street Zen, moving from a ‘strong sell’ to a ‘sell’ rating. Despite this, several other analysts, including those from Canaccord Genuity Group and Wedbush, have issued ‘buy’ or ‘outperform’ ratings with price targets ranging between $19.00 and $22.00.

International Flavors & Fragrances Inc. (IFF) has shown positive stock performance, trading at $84.31, which represents a 25.1% increase since the beginning of the year. Analysts maintain a ‘Moderate Buy’ consensus for the company, with an average price target of $92.16, suggesting potential for further growth as the market responds to the company’s restructuring and efficiency programs.